Answers are grounded in this paper and cite their sources.
The safety profile of COVID-19 vaccines in immunocompromised patients has not been comprehensively evaluated.
No takes yet. Share an insight, caveat, or question.
Bellitto et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: